Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of Hysterectomy
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Aarhus
University of California, Irvine
M.D. Anderson Cancer Center
Radiopharm Theranostics, Ltd
Zhejiang University
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
Cedars-Sinai Medical Center
Memorial Sloan Kettering Cancer Center
Baylor Research Institute
Karolinska University Hospital
UNC Lineberger Comprehensive Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Biogenea Pharmaceuticals Ltd.
Memorial Sloan Kettering Cancer Center
Abramson Cancer Center at Penn Medicine
Mayo Clinic
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Anhui Provincial Hospital
Thomas Jefferson University
Jonsson Comprehensive Cancer Center
The University of Hong Kong
National Cancer Institute (NCI)
University of South Florida
Mayo Clinic
Ohio State University Comprehensive Cancer Center
Peking University
National Cancer Institute (NCI)
Five Prime Therapeutics, Inc.
Geisinger Clinic
Haukeland University Hospital
Second Xiangya Hospital of Central South University
Mayo Clinic
Shantou University Medical College
Columbia University
Beijing Kejing Biotechnology Co., Ltd.
Duke University
OHSU Knight Cancer Institute
Mainline Biosciences, Inc.
UNC Lineberger Comprehensive Cancer Center
Shanghai Yunying Medical Technology
OHSU Knight Cancer Institute
Shanghai Yunying Medical Technology
Shanghai Yunying Medical Technology
National Cancer Institute (NCI)
University of Oklahoma
Fifth Affiliated Hospital, Sun Yat-Sen University